Literature DB >> 8338046

Secondary hyperparathyroidism in elderly people: combined effect of renal insufficiency and vitamin D deficiency.

R Freaney1, Y McBrinn, M J McKenna.   

Abstract

The relative effects of renal insufficiency and vitamin D deficiency on parathyroid gland function were assessed in 29 free-living elderly subjects by using a sensitive assay for intact parathyroid hormone (PTH). Serum calcium, phosphate, alkaline phosphatase, creatinine, 25-hydroxyvitamin D [25(OH)D], and PTH were measured after an overnight fast during wintertime, after oral vitamin D therapy (20 micrograms cholecalciferol/d for 4 wk), and at the end of the subsequent summer. Hypovitaminosis D [serum 25(OH)D < 25 nmol/L] was evident in 86% of the subjects during wintertime and 52% had elevated PTH concentrations. Multiple-regression analysis identified serum creatinine as the strongest predictor variable for serum PTH (multiple r = 0.73, P < 0.001). Mean (+/- SD) serum PTH declined from 6.3 +/- 2.8 to 5.0 +/- 2.0 pmol/L (P < 0.001) by the end of the summer season, coincident with an increase in serum 25(OH)D). Secondary hyperparathyroidism is common in elderly people, and in Ireland is the result of both renal insufficiency and hypovitaminosis D.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8338046     DOI: 10.1093/ajcn/58.2.187

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  14 in total

1.  Vitamin D intake and status in Irish elderly women and adolescent girls.

Authors:  D McCarthy; A Collins; M O'Brien; C Lamberg-Allardt; J Jakobsen; J Charzewska; M Kiely; A Flynn; K D Cashman
Journal:  Ir J Med Sci       Date:  2006 Apr-Jun       Impact factor: 1.568

2.  Osteoporosis prevention: from vitamin D to HRT.

Authors:  M J McKenna
Journal:  Ir J Med Sci       Date:  1997 Jul-Sep       Impact factor: 1.568

3.  Vitamin D supplementation versus combined calcium and vitamin D in older female patients - an observational study.

Authors:  T Dinizulu; D Griffin; J Carey; E Mulkerrin
Journal:  J Nutr Health Aging       Date:  2011-08       Impact factor: 4.075

4.  High prevalence of hypovitaminosis D in pregnant Japanese women with threatened premature delivery.

Authors:  Megumi Shibata; Atsushi Suzuki; Takao Sekiya; Sahoko Sekiguchi; Shogo Asano; Yasuhiro Udagawa; Mitsuyasu Itoh
Journal:  J Bone Miner Metab       Date:  2011-03-08       Impact factor: 2.626

5.  Hypovitaminosis D in a healthy female population, aged from 40 to 85 years, in the west of Ireland.

Authors:  E Lardner; M Fitzgibbon; S Wilson; D Griffin; E Mulkerrin
Journal:  Ir J Med Sci       Date:  2010-08-17       Impact factor: 1.568

Review 6.  Vitamin D supplementation in the elderly: review of safety and effectiveness of different regimes.

Authors:  P M Byrne; R Freaney; M J McKenna
Journal:  Calcif Tissue Int       Date:  1995-06       Impact factor: 4.333

7.  Increases in summer serum 25-hydroxyvitamin D (25OHD) concentrations in elderly subjects in São Paulo, Brazil vary with age, gender and ethnicity.

Authors:  Sergio S Maeda; Ilda S Kunii; Lilian F Hayashi; Marise Lazaretti-Castro
Journal:  BMC Endocr Disord       Date:  2010-06-14       Impact factor: 2.763

8.  Factors affecting vitamin D status in different populations in the city of São Paulo, Brazil: the São PAulo vitamin D Evaluation Study (SPADES).

Authors:  Sergio Setsuo Maeda; Gabriela Luporini Saraiva; Ilda Sizue Kunii; Lilian Fukusima Hayashi; Maysa Seabra Cendoroglo; Luiz Roberto Ramos; Marise Lazaretti-Castro
Journal:  BMC Endocr Disord       Date:  2013-04-29       Impact factor: 2.763

9.  Dermatitis herpetiformis: no evidence of bone disease despite evidence of enteropathy.

Authors:  M Abuzakouk; L Barnes; N O'Gorman; A O'Grady; B Mohamed; M J McKenna; R Freaney; C Feighery
Journal:  Dig Dis Sci       Date:  2007-03       Impact factor: 3.487

10.  Rising trend in vitamin D status from 1993 to 2013: dual concerns for the future.

Authors:  Malachi J McKenna; Barbara F Murray; Myra O'Keane; Mark T Kilbane
Journal:  Endocr Connect       Date:  2015-06-01       Impact factor: 3.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.